 Austin Gillen
Concepts (242)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Polyadenylation | 4 | 2022 | 37 | 1.680 |
Why?
| | Cystic Fibrosis Transmembrane Conductance Regulator | 7 | 2019 | 287 | 1.540 |
Why?
| | Single-Cell Analysis | 6 | 2020 | 188 | 1.040 |
Why?
| | Hibernation | 2 | 2023 | 72 | 0.940 |
Why?
| | Torpor | 2 | 2023 | 14 | 0.890 |
Why?
| | Neoplastic Cells, Circulating | 2 | 2020 | 59 | 0.860 |
Why?
| | Transcriptome | 4 | 2021 | 727 | 0.680 |
Why?
| | Gene Expression Regulation | 6 | 2023 | 2321 | 0.680 |
Why?
| | Sequence Analysis, RNA | 7 | 2022 | 388 | 0.650 |
Why?
| | High-Throughput Nucleotide Sequencing | 4 | 2021 | 440 | 0.630 |
Why?
| | Ependymoma | 1 | 2020 | 156 | 0.620 |
Why?
| | Breast Neoplasms | 7 | 2020 | 1868 | 0.620 |
Why?
| | Chromosomes, Artificial, Bacterial | 2 | 2019 | 18 | 0.610 |
Why?
| | Leukemia, Myeloid, Acute | 5 | 2023 | 536 | 0.600 |
Why?
| | Transgenes | 2 | 2019 | 170 | 0.570 |
Why?
| | Gene Regulatory Networks | 2 | 2018 | 228 | 0.560 |
Why?
| | Immunoprecipitation | 2 | 2016 | 152 | 0.550 |
Why?
| | Carcinogenesis | 1 | 2017 | 180 | 0.520 |
Why?
| | Respiratory Mucosa | 1 | 2018 | 251 | 0.510 |
Why?
| | RNA-Binding Proteins | 3 | 2023 | 344 | 0.510 |
Why?
| | Artifacts | 1 | 2016 | 113 | 0.510 |
Why?
| | Mitochondrial Proteins | 1 | 2017 | 219 | 0.510 |
Why?
| | 3' Untranslated Regions | 5 | 2022 | 129 | 0.510 |
Why?
| | Binding Sites | 2 | 2016 | 1176 | 0.440 |
Why?
| | MicroRNAs | 4 | 2016 | 601 | 0.440 |
Why?
| | Receptors, Estrogen | 5 | 2020 | 372 | 0.420 |
Why?
| | Gene Transfer Techniques | 1 | 2013 | 147 | 0.400 |
Why?
| | RNA | 2 | 2023 | 810 | 0.380 |
Why?
| | Bridged Bicyclo Compounds, Heterocyclic | 4 | 2022 | 172 | 0.380 |
Why?
| | Repressor Proteins | 2 | 2011 | 367 | 0.370 |
Why?
| | Regulatory Sequences, Nucleic Acid | 3 | 2019 | 81 | 0.370 |
Why?
| | Cystic Fibrosis | 2 | 2018 | 955 | 0.360 |
Why?
| | Cell Differentiation | 4 | 2021 | 1699 | 0.350 |
Why?
| | Sulfonamides | 4 | 2022 | 445 | 0.330 |
Why?
| | Mammals | 2 | 2023 | 245 | 0.320 |
Why?
| | Homeodomain Proteins | 4 | 2021 | 463 | 0.310 |
Why?
| | Interferon-gamma | 1 | 2011 | 722 | 0.300 |
Why?
| | Transcription, Genetic | 2 | 2012 | 1316 | 0.270 |
Why?
| | Non-alcoholic Fatty Liver Disease | 2 | 2020 | 245 | 0.270 |
Why?
| | Gene Expression Regulation, Neoplastic | 5 | 2018 | 1147 | 0.270 |
Why?
| | Animals | 18 | 2023 | 31761 | 0.240 |
Why?
| | Gene Expression | 2 | 2023 | 1420 | 0.240 |
Why?
| | Signal Transduction | 6 | 2020 | 4521 | 0.240 |
Why?
| | Humans | 34 | 2023 | 114716 | 0.240 |
Why?
| | Sciuridae | 2 | 2023 | 142 | 0.230 |
Why?
| | RNA, Messenger | 5 | 2021 | 2557 | 0.220 |
Why?
| | MCF-7 Cells | 3 | 2020 | 105 | 0.220 |
Why?
| | Nonsense Mediated mRNA Decay | 1 | 2023 | 8 | 0.220 |
Why?
| | Protein Isoforms | 2 | 2022 | 339 | 0.220 |
Why?
| | Muscular Dystrophy, Facioscapulohumeral | 1 | 2023 | 15 | 0.220 |
Why?
| | Antineoplastic Agents, Hormonal | 2 | 2021 | 138 | 0.210 |
Why?
| | Lipoproteins, LDL | 2 | 2020 | 128 | 0.210 |
Why?
| | Lymphatic Vessels | 2 | 2020 | 54 | 0.210 |
Why?
| | Estrogens | 4 | 2018 | 312 | 0.210 |
Why?
| | Liver | 2 | 2020 | 1631 | 0.200 |
Why?
| | Mice | 13 | 2022 | 14916 | 0.200 |
Why?
| | Azacitidine | 2 | 2022 | 129 | 0.190 |
Why?
| | Mammary Neoplasms, Experimental | 1 | 2021 | 64 | 0.190 |
Why?
| | Drosophila | 1 | 2022 | 133 | 0.190 |
Why?
| | Weight Gain | 2 | 2021 | 452 | 0.190 |
Why?
| | Leukocytes, Mononuclear | 2 | 2020 | 493 | 0.180 |
Why?
| | Adipose Tissue | 2 | 2021 | 539 | 0.180 |
Why?
| | Cells, Cultured | 6 | 2019 | 3890 | 0.180 |
Why?
| | RNA, Small Cytoplasmic | 1 | 2020 | 6 | 0.180 |
Why?
| | DNA-Binding Proteins | 3 | 2020 | 1314 | 0.180 |
Why?
| | Mouse Embryonic Stem Cells | 1 | 2020 | 22 | 0.170 |
Why?
| | rac GTP-Binding Proteins | 1 | 2020 | 34 | 0.170 |
Why?
| | Neural Crest | 1 | 2021 | 117 | 0.170 |
Why?
| | Decision Support Systems, Clinical | 1 | 2022 | 176 | 0.170 |
Why?
| | Gene Library | 2 | 2019 | 114 | 0.170 |
Why?
| | Extracellular Fluid | 1 | 2019 | 30 | 0.170 |
Why?
| | rho GTP-Binding Proteins | 1 | 2020 | 61 | 0.170 |
Why?
| | Neoplastic Stem Cells | 2 | 2023 | 334 | 0.170 |
Why?
| | Integrins | 1 | 2020 | 79 | 0.170 |
Why?
| | Myeloid-Lymphoid Leukemia Protein | 1 | 2020 | 62 | 0.160 |
Why?
| | Hedgehog Proteins | 1 | 2020 | 173 | 0.160 |
Why?
| | Promoter Regions, Genetic | 3 | 2013 | 1133 | 0.160 |
Why?
| | Neural Stem Cells | 1 | 2020 | 115 | 0.160 |
Why?
| | Receptors, Progesterone | 2 | 2020 | 319 | 0.160 |
Why?
| | Software | 2 | 2020 | 536 | 0.160 |
Why?
| | Epithelial-Mesenchymal Transition | 1 | 2020 | 168 | 0.160 |
Why?
| | Hematopoiesis | 1 | 2020 | 172 | 0.160 |
Why?
| | Histone-Lysine N-Methyltransferase | 1 | 2020 | 95 | 0.160 |
Why?
| | Oligodendroglia | 1 | 2020 | 148 | 0.160 |
Why?
| | RNA Editing | 1 | 2018 | 20 | 0.160 |
Why?
| | Zebrafish Proteins | 1 | 2021 | 246 | 0.160 |
Why?
| | Motor Neurons | 1 | 2020 | 212 | 0.150 |
Why?
| | Alveolar Epithelial Cells | 1 | 2019 | 93 | 0.150 |
Why?
| | Drug Resistance, Neoplasm | 2 | 2020 | 642 | 0.150 |
Why?
| | Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2018 | 51 | 0.150 |
Why?
| | Bleomycin | 1 | 2019 | 228 | 0.150 |
Why?
| | Neoplasm Metastasis | 1 | 2020 | 528 | 0.150 |
Why?
| | Obesity | 2 | 2021 | 2513 | 0.150 |
Why?
| | Superoxide Dismutase | 1 | 2019 | 305 | 0.150 |
Why?
| | Regeneration | 1 | 2019 | 160 | 0.140 |
Why?
| | RNA Polymerase III | 1 | 2017 | 25 | 0.140 |
Why?
| | Zebrafish | 1 | 2021 | 411 | 0.140 |
Why?
| | Hepatitis C, Chronic | 1 | 2019 | 151 | 0.140 |
Why?
| | Progestins | 1 | 2017 | 75 | 0.140 |
Why?
| | Biomarkers, Tumor | 2 | 2020 | 1053 | 0.140 |
Why?
| | Epithelial Cells | 2 | 2013 | 955 | 0.140 |
Why?
| | Cancer-Associated Fibroblasts | 1 | 2016 | 10 | 0.140 |
Why?
| | Gene Expression Profiling | 6 | 2020 | 1521 | 0.140 |
Why?
| | Lung Injury | 1 | 2019 | 197 | 0.140 |
Why?
| | Bronchi | 1 | 2018 | 232 | 0.130 |
Why?
| | Macrophages, Alveolar | 1 | 2019 | 347 | 0.130 |
Why?
| | Transforming Growth Factor beta | 1 | 2019 | 449 | 0.130 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 2 | 2022 | 1361 | 0.130 |
Why?
| | Epididymis | 2 | 2013 | 9 | 0.130 |
Why?
| | Trachea | 1 | 2018 | 223 | 0.130 |
Why?
| | Hypoxia | 1 | 2022 | 957 | 0.130 |
Why?
| | Extracellular Matrix | 1 | 2019 | 435 | 0.130 |
Why?
| | Apoptosis | 3 | 2019 | 2369 | 0.130 |
Why?
| | Disease-Free Survival | 1 | 2017 | 623 | 0.130 |
Why?
| | Temperature | 1 | 2018 | 575 | 0.130 |
Why?
| | Ribosomal Proteins | 1 | 2015 | 70 | 0.130 |
Why?
| | Neoplasms | 2 | 2021 | 2105 | 0.120 |
Why?
| | Sequence Analysis, DNA | 1 | 2018 | 728 | 0.120 |
Why?
| | DNA Primers | 1 | 2016 | 514 | 0.120 |
Why?
| | Reactive Oxygen Species | 1 | 2017 | 536 | 0.120 |
Why?
| | CCCTC-Binding Factor | 2 | 2011 | 12 | 0.120 |
Why?
| | Chromosome Mapping | 2 | 2013 | 489 | 0.120 |
Why?
| | Endothelial Cells | 1 | 2019 | 681 | 0.110 |
Why?
| | Tamoxifen | 3 | 2021 | 192 | 0.110 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2016 | 928 | 0.110 |
Why?
| | Gene Expression Regulation, Developmental | 2 | 2021 | 799 | 0.110 |
Why?
| | Spermatogenesis | 1 | 2013 | 52 | 0.110 |
Why?
| | Nucleosomes | 2 | 2013 | 122 | 0.110 |
Why?
| | Infertility, Male | 1 | 2013 | 59 | 0.110 |
Why?
| | Enhancer Elements, Genetic | 2 | 2012 | 152 | 0.110 |
Why?
| | Down-Regulation | 1 | 2015 | 596 | 0.110 |
Why?
| | Cluster Analysis | 3 | 2022 | 460 | 0.110 |
Why?
| | Chromatin Assembly and Disassembly | 1 | 2013 | 88 | 0.110 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 1 | 2014 | 193 | 0.100 |
Why?
| | In Situ Hybridization, Fluorescence | 1 | 2013 | 313 | 0.100 |
Why?
| | Genetic Vectors | 1 | 2013 | 291 | 0.100 |
Why?
| | Mitochondria | 1 | 2017 | 751 | 0.100 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2015 | 447 | 0.100 |
Why?
| | Sensitivity and Specificity | 1 | 2016 | 1690 | 0.100 |
Why?
| | Genes, Regulator | 1 | 2011 | 34 | 0.100 |
Why?
| | Caco-2 Cells | 1 | 2011 | 66 | 0.100 |
Why?
| | Tumor Microenvironment | 3 | 2020 | 433 | 0.090 |
Why?
| | Hypertension, Pulmonary | 1 | 2022 | 1728 | 0.090 |
Why?
| | Luciferases | 1 | 2011 | 142 | 0.090 |
Why?
| | Mice, Transgenic | 3 | 2021 | 1951 | 0.090 |
Why?
| | RNA Processing, Post-Transcriptional | 1 | 2011 | 82 | 0.090 |
Why?
| | Protein Binding | 1 | 2016 | 1896 | 0.090 |
Why?
| | Mice, Inbred C57BL | 4 | 2021 | 4710 | 0.090 |
Why?
| | Female | 11 | 2021 | 59486 | 0.090 |
Why?
| | Insulator Elements | 1 | 2009 | 2 | 0.080 |
Why?
| | 3' Flanking Region | 1 | 2009 | 7 | 0.080 |
Why?
| | Inflammation | 1 | 2019 | 2481 | 0.080 |
Why?
| | Blotting, Western | 1 | 2011 | 1151 | 0.080 |
Why?
| | CD146 Antigen | 2 | 2020 | 35 | 0.080 |
Why?
| | Tumor Cells, Cultured | 2 | 2020 | 854 | 0.070 |
Why?
| | Brain | 1 | 2018 | 2369 | 0.070 |
Why?
| | Chromatin | 1 | 2009 | 428 | 0.060 |
Why?
| | Disease Progression | 2 | 2023 | 2384 | 0.060 |
Why?
| | Antigens, CD34 | 1 | 2023 | 89 | 0.050 |
Why?
| | Serine-Arginine Splicing Factors | 1 | 2023 | 18 | 0.050 |
Why?
| | Male | 8 | 2022 | 55558 | 0.050 |
Why?
| | Mice, Obese | 1 | 2021 | 53 | 0.050 |
Why?
| | Aromatase Inhibitors | 1 | 2021 | 49 | 0.050 |
Why?
| | Child | 1 | 2020 | 18352 | 0.050 |
Why?
| | Thinness | 1 | 2021 | 87 | 0.050 |
Why?
| | Intercellular Junctions | 1 | 2020 | 33 | 0.050 |
Why?
| | Organogenesis | 1 | 2021 | 54 | 0.040 |
Why?
| | Proteostasis | 1 | 2020 | 20 | 0.040 |
Why?
| | Disease Models, Animal | 2 | 2020 | 3542 | 0.040 |
Why?
| | Head | 1 | 2021 | 85 | 0.040 |
Why?
| | Permeability | 1 | 2020 | 148 | 0.040 |
Why?
| | Embryoid Bodies | 1 | 2020 | 7 | 0.040 |
Why?
| | Morphogenesis | 1 | 2021 | 161 | 0.040 |
Why?
| | Skull | 1 | 2021 | 119 | 0.040 |
Why?
| | Colony-Forming Units Assay | 1 | 2020 | 89 | 0.040 |
Why?
| | Prognosis | 2 | 2020 | 3334 | 0.040 |
Why?
| | Cartilage | 1 | 2021 | 182 | 0.040 |
Why?
| | Transcription Factors | 2 | 2021 | 1528 | 0.040 |
Why?
| | Diet, High-Fat | 1 | 2020 | 225 | 0.040 |
Why?
| | Machine Learning | 1 | 2022 | 318 | 0.040 |
Why?
| | Exocytosis | 1 | 2019 | 89 | 0.040 |
Why?
| | Tricarboxylic Acids | 1 | 2018 | 10 | 0.040 |
Why?
| | Gene Editing | 1 | 2019 | 57 | 0.040 |
Why?
| | Antibiotics, Antineoplastic | 1 | 2019 | 109 | 0.040 |
Why?
| | Ketoglutaric Acids | 1 | 2018 | 15 | 0.040 |
Why?
| | Mesoderm | 1 | 2020 | 138 | 0.040 |
Why?
| | Electron Transport Complex II | 1 | 2018 | 23 | 0.040 |
Why?
| | Succinate Dehydrogenase | 1 | 2018 | 42 | 0.040 |
Why?
| | DNA, Complementary | 1 | 2019 | 257 | 0.040 |
Why?
| | Neoplasm Invasiveness | 1 | 2020 | 445 | 0.040 |
Why?
| | Loss of Function Mutation | 1 | 2018 | 36 | 0.040 |
Why?
| | Lung | 2 | 2022 | 3546 | 0.040 |
Why?
| | Primary Cell Culture | 1 | 2019 | 149 | 0.040 |
Why?
| | Tumor Suppressor Proteins | 1 | 2020 | 282 | 0.040 |
Why?
| | Cell Adhesion | 1 | 2020 | 430 | 0.040 |
Why?
| | Cell Line, Tumor | 2 | 2015 | 2725 | 0.040 |
Why?
| | Receptor, ErbB-2 | 1 | 2020 | 301 | 0.040 |
Why?
| | Aged, 80 and over | 2 | 2019 | 6346 | 0.040 |
Why?
| | Oxidative Phosphorylation | 1 | 2018 | 156 | 0.040 |
Why?
| | Fatty Acids | 1 | 2020 | 382 | 0.040 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 2018 | 213 | 0.040 |
Why?
| | Fibrosis | 1 | 2019 | 453 | 0.040 |
Why?
| | Amino Acids | 1 | 2020 | 448 | 0.040 |
Why?
| | Aged | 3 | 2020 | 19079 | 0.040 |
Why?
| | Hematopoietic Stem Cells | 1 | 2020 | 345 | 0.030 |
Why?
| | ErbB Receptors | 1 | 2020 | 560 | 0.030 |
Why?
| | Mice, SCID | 1 | 2017 | 320 | 0.030 |
Why?
| | Lymphatic Metastasis | 1 | 2017 | 280 | 0.030 |
Why?
| | Stem Cells | 1 | 2020 | 546 | 0.030 |
Why?
| | Lipopolysaccharides | 1 | 2019 | 812 | 0.030 |
Why?
| | Mice, Inbred NOD | 1 | 2017 | 561 | 0.030 |
Why?
| | Proto-Oncogene Proteins c-mdm2 | 1 | 2015 | 56 | 0.030 |
Why?
| | Fibroblasts | 1 | 2020 | 838 | 0.030 |
Why?
| | Macrophages | 1 | 2022 | 1261 | 0.030 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2017 | 706 | 0.030 |
Why?
| | Evolution, Molecular | 1 | 2018 | 437 | 0.030 |
Why?
| | Receptors, Steroid | 1 | 2014 | 47 | 0.030 |
Why?
| | Expert Systems | 1 | 2013 | 3 | 0.030 |
Why?
| | DNA, Intergenic | 1 | 2013 | 24 | 0.030 |
Why?
| | Energy Metabolism | 1 | 2018 | 729 | 0.030 |
Why?
| | Neoplasm Grading | 1 | 2014 | 242 | 0.030 |
Why?
| | Chronic Disease | 1 | 2019 | 1590 | 0.030 |
Why?
| | Mice, Knockout | 1 | 2019 | 2582 | 0.030 |
Why?
| | Organ Specificity | 1 | 2013 | 268 | 0.030 |
Why?
| | RNA Interference | 1 | 2014 | 437 | 0.030 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2019 | 1892 | 0.030 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2013 | 743 | 0.020 |
Why?
| | Diet | 1 | 2018 | 1080 | 0.020 |
Why?
| | Conserved Sequence | 1 | 2011 | 218 | 0.020 |
Why?
| | Rats | 1 | 2019 | 4943 | 0.020 |
Why?
| | Cell Proliferation | 1 | 2017 | 2196 | 0.020 |
Why?
| | Computational Biology | 1 | 2013 | 530 | 0.020 |
Why?
| | Biomarkers | 1 | 2020 | 3414 | 0.020 |
Why?
| | Fetus | 1 | 2013 | 699 | 0.020 |
Why?
| | DNA Footprinting | 1 | 2009 | 28 | 0.020 |
Why?
| | Deoxyribonuclease I | 1 | 2009 | 35 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2022 | 9089 | 0.020 |
Why?
| | Base Sequence | 1 | 2011 | 2118 | 0.020 |
Why?
| | Genome-Wide Association Study | 1 | 2013 | 1197 | 0.020 |
Why?
| | Adult | 2 | 2019 | 30543 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2014 | 2538 | 0.020 |
Why?
| | Middle Aged | 1 | 2019 | 26746 | 0.010 |
Why?
|
|
Gillen's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|